Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
U.S. health insurer Aetna Inc. (AET - Analyst Report) signed an agreement to acquire Coventry Health Care Inc. (CVH) for $7.3 billion. The purchase consideration also included takeover of the latter’s debt.
Per the agreement, shareholders of Coventry will get $27.30 in cash and 0.3885 Aetna common shares for each Coventry share, or $42.08 per share, based on the closing price of Aetna common shares on Friday, August 17, 2012.
Aetna is expected to issue $2.5 billion of debt and use the existing cash in hand to finance the deal. Though this will increase the company’s leverage ratio, it is expected to decline over time.
The deal is likely to close by mid 2013. Excluding transaction and integration costs, the transaction is anticipated to be modestly accretive to Aetna’s operating earnings in 2013. Moreover, it may add 45 cents per share to its operating earnings in 2014 and 90 cents per share in 2015.
Coventry is a niche player in the Medicare Advantage (“MA”) and Medicare Part D programs, as well as in Medicaid managed care plans, group and individual health insurance. It also provides coverage for specialty services, such as workers’ compensation and network rental services. The long-term strategic advantage of the deal is that it will allow Aetna to enhance its revenue share in the Government business (MA and Medicare Part D) to 30% from the present 23%.
Last year in October, Aetna closed its acquisition of Genworth’s Medigap business for $290 million.
The health insurance sector has been witnessing an increasing interest in the Medicare Advantage space for quite a long time. An MA plan is a government program, but is offered by commercial insurers to Medicare beneficiaries.
As baby boomers hit their retirement ages, they will opt for managed care plans. Health Insurers are thus planning to acquire providers of managed care plans to the seniors that in turn will help it generate higher revenues. Also, managed-care plans for Medicare are expected to generate incremental revenue of $10 billion by 2015, which would make such acquisitions valuable.
Carriers in the health insurance sector are competing with each other to win MA market share and the fastest way of doing this is to plan for such acquisitions. The recent deals show that the pace of merger and acquisition activity in this arena is quite high.
UnitedHealth Group Inc. (UNH - Analyst Report) acquired XLHealth Corp, a sponsor of Medicare Advantage health plans, and also bought Brentwood based Inspiris to increase its Medicare Advantage business.
Similarly, Humana Inc. (HUM - Analyst Report) is set to acquire Arcadian Management Services and MD Care. Both deals are expected to close before the end of 2012 and enhance Humana’s MA membership by 4.1% upon completion.
On October 1, 2011, Aetna closed its acquisition of Genworth’s Medigap business for $290 million.
In addition, WellPoint Inc. (WLP - Analyst Report), another big health insurer, bought CareMore Health Group.
Get the full Analyst Report on AET - FREE
Get the full Analyst Report on WLP - FREE
Get the full Analyst Report on HUM - FREE
Get the full Analyst Report on UNH - FREE